Association between the monocyte chemoattractant protein-1 -2518G/A gene polymorphism and acute myocardial infarction patients among Egyptian population

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 1, 2011, Pages 7-13

  El Mahgoub, Iman R ^a   Afify, Reham A ^a   Aal, Asmaa A Abdel ^a   Beda, Dalia G ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL HEART INSTITUTE   (Egypt)

Author keywords

2518G A polymorphism; monocyte chemoattractant protein 1; myocardial infarction; PCR RFLP

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EGYPT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

CHEMOKINE CCL2; EGYPT; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 78650776538     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328340126c     Document Type: Article

References (43)

1. Burke A, Virmani R. Pathophysiology of acute myocardial infarction. Medical Clin N Am 2007; 91:553-572.
2. Morimoto H, Takahashi M. Role of monocyte chemoattractant protein-1 in myocardial infarction. Int J Biomed Sci 2007; 3:159-167.
3. Eriksson EE. Mechanism of leukocyte recruitment to atherosclerotic lesion: Future prospects. Curr Opin Lipidol 2004; 15:553-558.
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
5. Rovin BH, Lu L, Saxena R. A novel polymorphism in MCP-1 gene regulatoty region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259:344-348.
6. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, et al. Plasma level of the monocyte chemotactic and activating factor /monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997; 29:419-423.
7. Cipollone F, Marini M, Faiza M, Pini B, Iezzi A, Reale M, et al. Elevated level of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Atheroscler Thromb Vasc Biol 2001; 21:327-334. (Pubitemid 32199112)
8. Hokimoto S, Ogawa H, Siato T, Oshima S, Noda K, Soejima H, et al. Increased plasma antigen levels of monocyte chemoattractant protein-1in patients with restenosis percutaneous transluminal coronary angioplasty. J Pn Circ J 2000; 64:831-834.
9. Aukrust P, Ueland T, Muller F, Andreassen AK, Nordøy I, Aas H, et al. Elevated circulating level of C-C Chemokines in patients with congestive heart failure. Circulation 1998; 97:1136-1143.
10. McDermott DH, Yang Q, Kathiresan S, Cupples LA, Massaro JM, Keaney JF, et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005; 112:1113-1120.
11. Simeoni E, Winkelmann BR, Hoffmann MM, Fleury S, Ruiz J, Kappenberger L, et al. Association of Rantes G-403A gene polymorphism with increased risk of coronary artherosclerosis. Eur Heart J 2004; 25:1438-1467.
12. Yamada Y, Izawa H, Ichilhara S, Takatsu F, Ishihara H, Hirayama H, et al. Prediction of the myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2003; 347:1916-1923.
13. Bjarnadottir K, Eiriksdottir G, Aspelund T, Gudnason V. Examination of genetic effects of polymorphism in the MCP-1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis 2006; 188:341-346.
14. Iwai N, Kajimoto K, Kokubo Y, Okayama A, Miyazaki S, Nonogi H, et al. Assessment of genetic effect of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese. Circ J 2006; 70:805-809.
15. Cermakova Z, Petrkova J, Arakelyan A, Drabek J, Mrazek F, Lukl J, Petrek M. The MCP-1 2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunol 2005; 32:315-318.
16. Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B, et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158:233-239.
17. Jemaa R, Rolbani H, Kallel A, Ali SB, Fekil M, Chabrak S, et al. Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta 2008; 390:122-125.
18. Cam F, Sekuri C, Sagcan A, Ercan E, Tengiz I, Alioglu E, Berdeli A. Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease. Scand J Clin Lab Invest 2008; 24:960-971.
19. Zhong C, Luzhan Z, Genshjan M, Jiahng W, Xiaoli Z, Qi Q. Monocyte chemoattractant protein-12518 G/A polymorphism, plasma levels, and premature stable coronary artery disease. Molec Biol Rep 2009; 27:1109-1115.
20. Kozam GT, Falus A, Bojszko A, Krikovszky D, Szabó T, Nagy A, Szalai C. Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1. Allergy 2002; 57:160-163.
21. Hwang SY, Cho ML, Park B, Kim JY, Kim YH, Min DJ, et al. Allelic frequency of MCP-1- promoter -2518 polymorphism in Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythrematosus and adult: onset still' s disease. Eur J Immunogenet 2002; 29:413-416.
22. Jibiki T, Terai M, Shima M, Ogawa A, Hamada H, Kanazawa M, et al. Monocyte chemoattractant protein-1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein-1 in Japanese patients with Kawasaki disease. Arthrit Rheum 2001; 44:2211-2212.
23. Kim M, Wahl L, Yanek L, Becker D, Becker L. A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a highrisk asymptomatic population. Atherosclerosis 2007; 193:366-372.
24. Allonso-Villaverde C, Coll B, Parra S, Montero M, Calvo N, Tous M, et al. Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. Circulation 2004; 110:2204-2209.
25. McGlinchey PG, Spence MS, Patterson CC, Allen AR, Murphy G, Belton C, McKeown PP. Lack of association between the 2518 G/A polymorphism of the MCP-1 gene and ischaemic heart disease: A family based investigation. Tissue Antigens 2004; 64:199-203.
26. Gonzalez P, Alvarez R, Battalla A, Reguero JR, Alvarez V, Astudillo A, et al. Genetic variation at the chemokine receptors CCR5/CCR2 in the myocardial infarction. Gene Immun 2001; 2:191-195.
27. Ridker PM, Buring JE, Cook NR, Rifai N. C- reactive protein, the metabolic syndrome and risk of incident cardiovascular events: An 8-years follow upof 14719 initially healthy American women. Circulation 2003; 107:391-397.
28. Kiechl S, Werner P, Egger G, Oberhollenzer F, Mayr M, Xu Q, et al. Active and passive smoking chronic infections, and risk of carotid atherosclerosis: Prospective results from the Bruneck study. Stroke 2002; 33:2170-2176.
29. Tracy PR, Pasty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Atheroscler Thromb Vase Biol 1997; 17:267-276.
30. Takeya M, Yoshimum T, Leonard EJ, Takahashi K. Detection of monocyte chemoattractant protein -1 in human atherosclerotic lesion by anti monocytes chemoattractant protein -1 monoclonal antibody. Hum Pathol 1993; 24:534-539.
31. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, et al. Expression of monocyte chemattractant protein -1 in macrophage-rich areas of human and rabbit atherosclerosis lesions. Proc Natl Acad Sci USA 1991; 88:5252-5256.
32. Dawson TC, Kuziel WA, Oshar TA, Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E- deficient mice. Atherosclerosis 1999; 143:205-211.
33. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394:894-897.
34. Cho ML, Kim JY, Kim YH, Kim WU, Cho CS, et al. The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity 2004; 37:77-80.
35. Valente AJ, Xie JF, Abramova MA, Wenzel UO, Abboud HE, Graves DT. A complex element regulate IFN-gamma-stimulated monocyte chemattractant protein-1gene transcription. Immunology 1998; 161:3719-3728.
36. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Ishigatsubo Y, et al. NFKappa B and Spl regulate the transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153:2.
37. Kaikita K, Hayasaki T, Okuma T, Kuziel WA, Ogawa H, Takeya M. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am J Pathol 2004; 165:439-447; 052-63.
38. Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N, et al. Antimonocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003; 108:2134-2140. (Pubitemid 37337591)
39. Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE, Ikeda U. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 2006; 99:891-899.
40. Martire A, Fernandez B, Buehler A, Strohm C, Schaper J, Zimmermann R, et al. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation. Cardiovasc Res 2003; 57:523-534.
41. Dewald O, Ren G, Duerr GD, Zoerlein M, Klemm C, Gersch C, et al. Species-specific differences in the inflammatory response following myocardial infarction of mice and dogs. Am J Pathol 2004; 164:665-677.
42. Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 1997; 95:693-700.
43. Takahashi M, Masuyama J, Ikeda U, Kitagawa S, Kasahara T, Saito M, et al. Suppressive role of endogenous endothelial monocyte chemoattractant protein-1 on monocyte transendothelial migration in vitro. Arterioscler Thromb Vasc Biol 1995; 15:629-636.